Skip to main content
Zur Rose Group AG logo

Zur Rose Group AG — Investor Relations & Filings

Ticker · ROSE ISIN · CH0042615283 LEI · 50670038OH136R5Z4663 SW Wholesale and retail trade
Open in API
Filings indexed 477 across all filing types
Latest filing 2024-07-11 Earnings Release
Country CH Switzerland
Listing SW ROSE

About Zur Rose Group AG

https://www.zurrosegroup.com/websites/z…

DocMorris AG, formerly Zur Rose Group AG, is a leading European e-commerce pharmacy. The company provides an online platform for medicines and develops digital health services. Its core strategy involves creating a comprehensive digital health ecosystem that connects patients, doctors, pharmacies, and health insurers on a single platform. The company's vision is to enable individuals to manage their health with a single click, offering integrated care and treatment solutions. Originally founded as a pharmacy wholesaler, it has evolved to focus on the digitalization of healthcare services.

Recent filings

Filing Released Lang Actions
DocMorris with accelerated and significant eRx growth in new customers, market share and revenue
Earnings Release Classification · 100% confidence The document is a press release dated July 11, 2024, detailing financial performance for the second quarter of 2024 (1.4.-30.6.2024) and the first half of 2024 (1.1.-30.6.2024). It highlights key metrics like revenue growth, eRx performance, and customer numbers. It explicitly states that the figures are 'preliminary' and that the 'detailed half-year report will be published on 20 August.' This structure—a brief announcement of period results with preliminary figures, often referencing a future, more detailed report—is characteristic of an Earnings Release (ER). It is not the comprehensive Interim/Quarterly Report (IR) itself, as that is scheduled for August 20th. It is also not a Call Transcript (CT) or a full Annual Report (10-K). Q2 2024
2024-07-11 English
DocMorris with accelerated and significant eRx growth in new customers, market share and revenue
Earnings Release Classification · 100% confidence The document is explicitly titled as a "Press release" dated 11.07.2024, detailing financial performance for the second quarter of 2024 (1.4.-30.6.2024) and providing preliminary revenue figures. It highlights key operational metrics (eRx growth) and financial results for a period shorter than a full year. This structure—a press release announcing preliminary results for a fiscal quarter—is characteristic of an Earnings Release (ER). Although it mentions that the detailed half-year report will be published later (implying an Interim Report (IR) is forthcoming), this specific document serves as the initial, high-level announcement of those results, fitting the definition of an Earnings Release (ER). H1 2024
2024-07-11 English
DocMorris mit beschleunigtem und signifikantem eRx-Wachstum bei Neukunden, Marktanteil und Umsatz
Earnings Release Classification · 100% confidence The document is explicitly titled a "Medienmitteilung" (Media Release) and reports on the financial performance for the second quarter (Q2 2024) and the first half of the year (1H 2024), highlighting key metrics like revenue growth and eRx adoption. It contains preliminary, unaudited figures ("ungeprüft, vorläufig") and explicitly states that the detailed half-year report will be published on August 20th. This structure—a press release summarizing period results before the comprehensive report is due—is characteristic of an Earnings Release (ER). It is not the full Interim/Quarterly Report (IR) itself, nor is it a general regulatory filing (RNS) given the specific financial content. Q2 2024
2024-07-11 German
DocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025
Capital/Financing Update Classification · 99% confidence The document is an 'Ad-hoc' announcement dated May 23, 2024, explicitly stating it is a 'Release of an ad hoc announcement pursuant to Art. 53 LR'. The content details the 'Early redemption of the 2.75% Convertible Bonds due 2025' by DocMorris Finance B.V. This action involves debt instruments (bonds) and financing decisions (redemption/conversion options). This falls under the category of updates related to company financing or capital structure changes. Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER: Not an earnings release. - DIV: Not a dividend announcement. - CAP (Capital/Financing Update): This category covers updates on company fundraising, financing activities, or capital structure changes. The early redemption of convertible bonds is a direct financing activity. - RNS (Regulatory Filings): While this is a regulatory filing (Ad hoc pursuant to Art. 53 LR), the CAP category is more specific to the *content* (financing/debt management). Since the document is a substantive announcement about a financing event rather than just a notice that a report is attached (which would suggest RPA/RNS), CAP is the best fit. Therefore, the document is classified as a Capital/Financing Update (CAP).
2024-05-23 English
DocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025
Capital/Financing Update Classification · 99% confidence The document is an 'Ad hoc announcement pursuant to Art. 53 LR' from DocMorris AG regarding the 'Early redemption of the 2.75% Convertible Bonds due 2025'. This announcement details a specific corporate action related to financing/capital structure (redemption of convertible bonds) and is issued outside of regular periodic reporting cycles (like 10-K or IR). It is not a full financial report (10-K, IR), an earnings release (ER), or a general proxy/shareholder vote document. It directly relates to the company's debt and capital instruments. This fits best under 'Capital/Financing Update' (CAP), as it concerns the early redemption and conversion options related to outstanding bonds.
2024-05-23 English
DocMorris AG: Vorzeitige Rückzahlung der 2,75%-Wandelanleihe mit Fälligkeit 2025
Capital/Financing Update Classification · 98% confidence The document is titled 'Ad hoc-Mitteilung gemäss Art. 53 KR' (Ad hoc announcement according to Art. 53 KR) and is published by DocMorris AG. It announces a specific corporate action: the early redemption of a convertible bond ('Vorzeitige Rückzahlung der 2,75%-Wandelanleihe mit Fälligkeit 2025'). This type of mandatory, price-sensitive disclosure, often related to financing or debt instruments, is typically classified as a general regulatory announcement or a specific financing update. Since it deals directly with the terms and redemption of a bond, it strongly relates to 'Capital/Financing Update' (CAP). However, the format is a standard, immediate regulatory disclosure ('Ad hoc-Mitteilung') used for material, non-periodic information, which often falls under the general regulatory filing category if a more specific one (like DIV or SHA) doesn't perfectly fit. Given the focus on debt instrument redemption and financing structure change, CAP is highly relevant. Since it is a full announcement detailing the terms of the redemption and conversion deadlines, it is the primary document, not just an announcement of a report (RPA). Comparing CAP and RNS: CAP is more specific to financing activities. I will classify it as CAP because the core subject is the bond redemption/financing event.
2024-05-23 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.